NCT00006264View on ClinicalTrials.gov

Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2000

Primary Completion Date

March 31, 2003

Study Completion Date

July 31, 2003

Conditions
Lymphoma
Interventions
BIOLOGICAL

aldesleukin

DRUG

ganciclovir

DRUG

zidovudine

Trial Locations (2)

33136

Sylvester Cancer Center, University of Miami, Miami

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

AIDS Malignancy Consortium

NETWORK

NCT00006264 - Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma | Biotech Hunter | Biotech Hunter